Stem cells and osteoporosis therapy

Steven L. Teitelbaum

doi:10.1016/j.stem.2010.10.004

Stem cells and osteoporosis therapy

Steven L. Teitelbaum

Research output: Contribution to journal › Short survey › peer-review

54 Scopus citations

Abstract

Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor β1, which is inhibited by a common antiosteoporosis drug.

Original language	English
Pages (from-to)	553-554
Number of pages	2
Journal	Cell Stem Cell
Volume	7
Issue number	5
DOIs	https://doi.org/10.1016/j.stem.2010.10.004
State	Published - Nov 5 2010

Access to Document

10.1016/j.stem.2010.10.004

Cite this

@article{51b483be0f62428fa9ad73664e9dccfe,

title = "Stem cells and osteoporosis therapy",

abstract = "Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor β1, which is inhibited by a common antiosteoporosis drug.",

author = "Teitelbaum, {Steven L.}",

year = "2010",

month = nov,

day = "5",

doi = "10.1016/j.stem.2010.10.004",

language = "English",

volume = "7",

pages = "553--554",

journal = "Cell Stem Cell",

issn = "1934-5909",

number = "5",

}

TY - JOUR

T1 - Stem cells and osteoporosis therapy

AU - Teitelbaum, Steven L.

PY - 2010/11/5

Y1 - 2010/11/5

N2 - Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor β1, which is inhibited by a common antiosteoporosis drug.

AB - Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor β1, which is inhibited by a common antiosteoporosis drug.

UR - http://www.scopus.com/inward/record.url?scp=78049511517&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.10.004

DO - 10.1016/j.stem.2010.10.004

M3 - Short survey

C2 - 21040895

AN - SCOPUS:78049511517

SN - 1934-5909

VL - 7

SP - 553

EP - 554

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 5

ER -

Stem cells and osteoporosis therapy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this